These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 17403966

  • 1. Fragile X syndrome: molecular mechanisms of cognitive dysfunction.
    Huber K.
    Am J Psychiatry; 2007 Apr; 164(4):556. PubMed ID: 17403966
    [No Abstract] [Full Text] [Related]

  • 2. [Neurological signs in the adult with fragile-X premutation].
    Cabanyes-Truffino J.
    Neurologia; 2010 May; 25(4):222-7. PubMed ID: 20609299
    [Abstract] [Full Text] [Related]

  • 3. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.
    Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, Ginger M, Frick A, DiPatrizio NV, Mackie K, Katona I, Piomelli D, Manzoni OJ.
    Nat Commun; 2012 May; 3():1080. PubMed ID: 23011134
    [Abstract] [Full Text] [Related]

  • 4. Mechanism-based approaches to treating fragile X.
    Dölen G, Carpenter RL, Ocain TD, Bear MF.
    Pharmacol Ther; 2010 Jul; 127(1):78-93. PubMed ID: 20303363
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Understanding Fragile X syndrome: molecular, cellular and genomic neuroscience at the crossroads.
    Moldin SO.
    Genes Brain Behav; 2005 Aug; 4(6):337-40. PubMed ID: 16098132
    [No Abstract] [Full Text] [Related]

  • 7. Biomedical research. A fix for fragile X syndrome?
    Miller G.
    Science; 2006 Apr 28; 312(5773):521. PubMed ID: 16645065
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroscience: fragile dopamine.
    Weinshenker D, Warren ST.
    Nature; 2008 Oct 02; 455(7213):607-8. PubMed ID: 18833269
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Altered Neuronal and Circuit Excitability in Fragile X Syndrome.
    Contractor A, Klyachko VA, Portera-Cailliau C.
    Neuron; 2015 Aug 19; 87(4):699-715. PubMed ID: 26291156
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Translating molecular advances in fragile X syndrome into therapy: a review.
    Hagerman RJ, Des-Portes V, Gasparini F, Jacquemont S, Gomez-Mancilla B.
    J Clin Psychiatry; 2014 Apr 19; 75(4):e294-307. PubMed ID: 24813413
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.